Skip to main content

Advertisement

Log in

Efficacy of 1-day prophylaxis medication with fluoroquinolone for prostate biopsy

  • Original Article
  • Published:
World Journal of Urology Aims and scope Submit manuscript

Abstract

A prospective, randomized trial in which 236 patients received oral levofloxacin, either at 600 mg/day for 1 day (n=124) or 300 mg/day for 3 days (n=112). Urinalysis, plasma white blood cell count (WBC) (per mm3), and C reactive protein (CRP) (mg/dl) levels were checked before prostate biopsy (PBX), on the day after PBX, and on the seventh day after PBX. Two patients (1.61%) who received 600 mg for 1 day and 2 patients (1.79%) who received 300 mg for 3 days had febrile infectious complications. There was no statistically significant difference between levofloxacin at 600 mg for 1 day and levofloxacin at 300 mg for 3 days regarding the elevation of WBC and CRP. We can perform PBX safely with levofloxacin at 600 mg for 1 day as prophylaxis and recommend this method from the point of view of the decrease of antibiotic-resistant strains.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Aron M, Rajeev TP, Gupta NP (2000) Antibiotic prophylaxis for transrectal needle biopsy of the prostate: a randomized controlled study. BJU Int 85:682–685

    Article  PubMed  CAS  Google Scholar 

  2. Bishop D, Oliver J (1977) A study of transrectal aspiration biopsies of the prostate, with particular regard to prognostic evaluation. J Urol 117:313–315

    PubMed  CAS  Google Scholar 

  3. Brewster SF, MacGowan AP, Gingell JC (1995) Antimicrobial prophylaxis for transrectal prostatic biopsy: a prospective randomized trial of cefuroxime versus piperacillin/tazobactam. Br J Urol 76:351–354

    Article  PubMed  CAS  Google Scholar 

  4. Carey JM, Korman HJ (2001) Transrectal ultrasound guided biopsy of the prostate. Do enemas decrease clinically significant complications? J Urol 166:82–85

    Article  PubMed  CAS  Google Scholar 

  5. Onder AU, Yaycioglu O, Ataus S, Gul U, Demirkesen O, Yalcin V, Solok V (2003) Transition zone biopsy and prediction of extraprostatic extension at radical prostatectomy. Int J Urol 10:302–308

    Article  PubMed  Google Scholar 

  6. Cormio L, Berardi B, Callea A, Fiorentino N, Sblendorio D, Zizzi V, Traficante A (2002) Antimicrobial prophylaxis for transrectal prostatic biopsy: a prospective study of ciprofloxacin vs piperacillin/tazobactam. BJU Int 90:700–702

    Article  PubMed  CAS  Google Scholar 

  7. Crawford ED, Haynes AL Jr, Story MW, Borden TA (1982) Prevention of urinary tract infection and sepsis following transrectal prostatic biopsy. J Urol 127:449–451

    PubMed  CAS  Google Scholar 

  8. Davis R, Bryson HM (1994) Levofloxacin. A review of its antibacterial activity, pharmacokinetics, and therapeutic efficacy. Drugs 48:132

    Article  Google Scholar 

  9. Desmond PM, Clark J, Thompson IM, Zeidman EJ, Mueller EJ (1993) Morbidity with contemporary prostate biopsy. J Urol 150:1425–1426

    PubMed  CAS  Google Scholar 

  10. Drusano GL, Preston SL, Van Guilder M (2000) A population pharmacokinetic analysis of the penetration of the prostate by levofloxacin. Antimicrob Agents Chemother 44:2046–2051

    Article  PubMed  CAS  Google Scholar 

  11. Fournier G, Valeri A, Mangin P, Cussenot O (2004) Prostate cancer: diagnosis and staging. Ann Urol (Paris) 38:207–224

    CAS  Google Scholar 

  12. Fujimoto N, Harada S, Sato H, Akasaka S, Nomura M, Yamada Y, Ueno Y, Matsumoto T (2004) Screening for prostate cancer in Yahata, Kitakyushu. J UOEH 26:239–244

    PubMed  Google Scholar 

  13. Griffith BC, Morey AF, Ali-Khan MM, Canby-Hagino E, Foley JP, Rozanski TA (2002) Single dose levofloxacin prophylaxis for prostate biopsy in patients at low risk. J Urol 168:1021–1023

    Article  PubMed  CAS  Google Scholar 

  14. Isen K, Kupeli B, Sinik Z, Sozen S, Bozkirli I (1999) Antibiotic prophylaxis for transrectal biopsy of the prostate: a prospective randomized study of the prophylactic use of single dose oral fluoroquinolone versus trimethoprim-sulfamethoxazole. Int Urol Nephrol 31:491–495

    Article  PubMed  CAS  Google Scholar 

  15. Kapoor DA, Klimberg IW, Malek GH, Wegenke JD, Cox CE, Patterson AL, Graam E, Echols RM, Whalen E, Kowalsky SF (1998) Single-dose oral ciprofloxacin versus placebo for prophylaxis during transrectal prostate biopsy. Urology 52:552–558

    Article  PubMed  CAS  Google Scholar 

  16. Larsen EH, Gasser TC, Madsen PO (1986) Antimicrobial prophylaxis in urologic surgery. Urol Clin North Am 4:591–604

    Google Scholar 

  17. Lindert KA, Kabalin JN, Terris MK (2000) Bacteremia and bacteriuria after transrectal ultrasound guided prostate biopsy. J Urol 164:76–80

    Article  PubMed  CAS  Google Scholar 

  18. Onder AU, Yaycioglu O, Ataus S, Gul U, Demirkesen O, Yalcin V, Solok V (2003) Transition zone biopsy and prediction of extraprostatic extension at radical prostatectomy. Int J Urol 10:302–308

    Article  PubMed  Google Scholar 

  19. Packer MG, Russo P, Fair WR (1984) Prophylactic antibiotics and Foley catheter use in transperineal needle biopsy of the prostate. J Urol 131:687–689

    PubMed  CAS  Google Scholar 

  20. Sieber PR, Rommel FM, Agusta VE, Breslin JA, Huffnagle HW, Harpster LE (1997) Antibiotic prophylaxis in ultrasound guided transrectal prostate biopsy. J Urol 157:2199–2200

    Article  PubMed  CAS  Google Scholar 

  21. Turner B, Warner J, Rhamy R (1980) Prostatic needle examination. South Med J 73:183–184

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Soichi Arakawa.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shigemura, K., Tanaka, K., Yasuda, M. et al. Efficacy of 1-day prophylaxis medication with fluoroquinolone for prostate biopsy. World J Urol 23, 356–360 (2005). https://doi.org/10.1007/s00345-005-0024-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00345-005-0024-4

Keywords

Navigation